Biofrontera Inc.
BFRI· Nasdaq
BFRIBiofrontera Inc.
Filed Aug 12, 2022 · 10-Q · 43 days after period end · 0001493152-22-022202
| Metric | Q2 2022 | Q2 2021 |
|---|---|---|
| Revenue | $4.46M | $5.86M |
| Net Income | -$850.00K | -$3.66M |
| EPS Diluted | -$0.90 | -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 12, 2022 · 43 d after period end
